Lund, Sweden, 2013-08-27 07:00 CEST (GLOBE NEWSWIRE) -- EXINI Diagnostics AB and FUJIFILM RI Pharma Co Ltd. have signed a five-year contract. FUJIFILM RI Pharma is given exclusive rights for the software EXINI heart on the Japanese market. In conjunction, the present contract for EXINI boneBSI has been extended for an additional five years. EXINI receives 28.4 MSEK for the licence agreements and a no-limit bonus. The projection for EXINI heart is expected to match EXINI boneBSI´s, thus rendering EXINI approximately 20 MSEK in bonuses for the contract period.
Help employers find you! Check out all the jobs and post your resume.
